See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2019_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 181,562,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,905,000 |
| 3 | remainder_Assets | 2,280,000 |
| 4 | LiabilitiesCurrent | 14,415,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,914,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,381,000 |
| 9 | ResearchAndDevelopmentExpense | 58,124,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -43,000 |
| 13 | remainder_ComprehensiveNetIncome | -14,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 186,747,000 |
| 1 | Liabilities | 16,329,000 |
| 2 | Expenses | 72,505,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 170,418,000 |
| 5 | NetIncome | -72,548,000 |
| 6 | ComprehensiveNetIncome | -72,555,000 |
| 7 | BaseVar | 137,819,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.94 |
| 9 | EconomicCapitalRatio | 3.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
